Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big

United States News News

Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
United States Latest News,United States Headlines
  • 📰 nbcsandiego
  • ⏱ Reading Time:
  • 43 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 51%

Drugmakers released cancer data at ASCO, with AstraZeneca taking center stage. A report found that digital physical therapy tools provide clinical benefits.

More than 5,000 research abstracts were presented or published at ASCO. They included data on existing drugs, experimental treatments, AI tools and ideas for improving patient care.reduced the risk of disease progression or death

TDCowen analyst Steve Scala wrote in a note Thursday that AstraZeneca's"abundance of positive data" at ASCO reinforces the company's $80 billion revenue target by 2030.without seeing their cancer progress, and most people experienced that benefit for over five years, according to data from a late-stage trial. The medicine also cut the risk of the cancer progressing in patients' brains.

Musculoskeletal conditions limit a patient's mobility and can affect the joints, bones and muscles. These disorders are often associated with pain, and they can be treated with medication, surgery or a form of rehabilitation like physical therapy. To assess the tools' clinical and economic performance, PHTI said it reviewed more than 2,000 scientific articles and received input from experts and patients.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

nbcsandiego /  🏆 524. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conferenceHealthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conferenceCNBC will be on the ground at the ASCO annual meeting in Chicago. Meanwhile, Epic released a free tool set to help health systems evaluate AI models.
Read more »

Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulinsHealthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulinsThe rivalry between Eli Lilly and Novo Nordisk extends beyond weight loss and diabetes drugs. Meanwhile, Uber has announced new features for caregivers.
Read more »

Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulinsHealthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulinsThe rivalry between Eli Lilly and Novo Nordisk extends beyond weight loss and diabetes drugs. Meanwhile, Uber has announced new features for caregivers.
Read more »

Bucs' Chris Godwin is healthy and eager for new role as he returns to slotBucs' Chris Godwin is healthy and eager for new role as he returns to slotChris Godwin has been a steady playmaker despite some recent injuries. Healthy and still just 28, the Bucs receiver could step into a larger role in the slot.
Read more »

Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey saysHealthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey saysA wide swath of Americans are using GLP-1s despite shortages, a survey says. Meanwhile, Google DeepMind’s new AI model can predict the structure of…
Read more »

Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey saysHealthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey saysA wide swath of Americans are using GLP-1s despite shortages, a survey says. Meanwhile, Google DeepMind’s new AI model can predict the structure of…
Read more »



Render Time: 2025-02-21 08:13:44